Sinonasal Cancer

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2026-04-13
Clinical Trial Update: Testing the Use of Investigational Drugs Atezolizumab and/or Bevacizumab With or Without Standard Chemotherapy in the Second-Line Treatment of Advanced-Stage Head and Neck Cancers [Phase 2, Phase 3]
This clinical trial update describes a Phase 2/Phase 3 study evaluating atezolizumab and/or bevacizumab with or without standard chemotherap…
CLINICAL_TRIALS research · 2026-03-04
Clinical Trial Update: TMV Vaccine Therapy Alone and With Pembrolizumab for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer [Phase 1]
Phase 1 trial evaluating TMV vaccine therapy alone and with pembrolizumab for recurrent/metastatic head and neck squamous cell carcinoma; cu…
CLINICAL_TRIALS research · 2026-02-19
Clinical Trial Update: A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC) [Phase 2]
Phase 2 clinical trial evaluating sacituzumab govitecan in combination with cetuximab for head and neck squamous cell cancers is currently r…
CLINICAL_TRIALS research · 2025-07-28
Clinical Trial Update: Phase II Study of Intensity Modulated Radiotherapy in Dose Painting for Sinus Carcinomas After Endoscopic Surgery [Phase 2]
Phase II trial evaluating intensity-modulated radiotherapy with dose painting for sinonasal cancer after endoscopic surgery; currently recru…
CLINICAL_TRIALS withdrawal · 2025-07-10
Clinical Trial Update: Study of Front Line Pembrolizumab and Valemetostat in PD-L1 Positive, HPV-Negative Recurrent/Metastatic Squamous Cell Carcinoma (SCC) of the Head and Neck: The PANTHERAS [Phase 1, Phase 2]
A Phase 1/2 study of frontline pembrolizumab plus valemetostat for PD-L1 positive, HPV-negative recurrent/metastatic squamous cell carcinoma…
Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
CLINICAL_TRIALS trial_result · 2025-07-09
Clinical Trial Update: Radiotherapy of Head and Neck Cancer Using an Intraoral Stent [Phase 2]
Phase 2 trial update on radiotherapy for head and neck cancers using an intraoral stent has completed. The study concerns oral cavity cancer…
CLINICAL_TRIALS research · 2025-06-26
Clinical Trial Update: Toripalimab With Chemotherapy for Sinus Cancer [Phase 2]
A Phase 2 clinical trial evaluating toripalimab in combination with chemotherapy for sinonasal cancer and related paranasal sinus neoplasms …
CLINICAL_TRIALS research · 2025-05-22
Clinical Trial Update: Exercise Training and Behavioral Modification for the Improvement of Physical Activity in Head and Neck Cancer Patients Undergoing Cancer Treatment [NA]
An update on a completed clinical trial evaluating exercise training and behavioral modification to boost physical activity in patients unde…
CLINICAL_TRIALS trial_result · 2018-04-09
Clinical Trial Update: Docetaxel Based Chemotherapy Plus or Minus Induction Chemotherapy to Decrease Events in Head and Neck Cancer (DeCIDE) [Phase 3]
A Phase 3 trial (DeCIDE) evaluated docetaxel-based chemotherapy with or without induction chemotherapy to reduce events in head and neck can…